These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3283291)

  • 1. Antidepressant drug therapy: associated risks.
    Amrein R; Allen SR; Vranesic D; Stabl M
    J Neural Transm Suppl; 1988; 26():73-86. PubMed ID: 3283291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo.
    Versiani M; Nardi AE; Figueira IL; Stabl M
    Acta Psychiatr Scand Suppl; 1990; 360():24-8. PubMed ID: 2123366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moclobemide: therapeutic use and clinical studies.
    Bonnet U
    CNS Drug Rev; 2003; 9(1):97-140. PubMed ID: 12595913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy reviews: tricyclic antidepressant and monoamine oxidase inhibitor combination therapy.
    Ponto LB; Perry PJ; Liskow BI; Seaba HH
    Am J Hosp Pharm; 1977 Sep; 34(9):954-61. PubMed ID: 333909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIMA--a new concept in the treatment of depression with moclobemide.
    Amrein R; Hetzel W; Stabl M; Schmid-Burgk W
    Int Clin Psychopharmacol; 1993 Jan; 7(3-4):123-32. PubMed ID: 8468432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between tyramine potentiation and monoamine oxidase (MAO) inhibition: comparison between moclobemide and other MAO inhibitors.
    Zimmer R
    Acta Psychiatr Scand Suppl; 1990; 360():81-3. PubMed ID: 2248084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG; Pugh DD
    Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyramine pressor response with moclobemide--a reversible monoamine oxidase inhibitor.
    Tiller JW; Maguire KP; Davies BM
    Psychiatry Res; 1987 Nov; 22(3):213-20. PubMed ID: 3432450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidepressant and tolerance: Determinants and management of major side effects].
    David DJ; Gourion D
    Encephale; 2016 Dec; 42(6):553-561. PubMed ID: 27423475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switch in treatment from tricyclic antidepressants to moclobemide: a new generation monoamine oxidase inhibitor.
    Dingemanse J; Kneer J; Fotteler B; Groen H; Peeters PA; Jonkman JH
    J Clin Psychopharmacol; 1995 Feb; 15(1):41-8. PubMed ID: 7714227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors (MAOI) or reversible inhibitors of monoamine oxidase (RIMA)/tricyclic antidepressant (TCA) combination therapy.
    Tiller JW; Mitchell P; Burrows GD
    Aust N Z J Psychiatry; 1992 Jun; 26(2):327-9. PubMed ID: 1642632
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of reversible inhibitors of monoamine oxidase-A in various forms of depression.
    Lecrubier Y; Guelfi JD
    Acta Psychiatr Scand Suppl; 1990; 360():18-23. PubMed ID: 2248063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk-benefit assessment of moclobemide in the treatment of depressive disorders.
    Norman TR; Burrows GD
    Drug Saf; 1995 Jan; 12(1):46-54. PubMed ID: 7741983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of comparative clinical trials. Moclobemide vs tricyclic antidepressants and vs placebo in depressive states.
    Stabl M; Biziére K; Schmid-Burgk W; Amrein R
    J Neural Transm Suppl; 1989; 28():77-89. PubMed ID: 2677244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyramine and new monoamine oxidase inhibitor drugs.
    Simpson GM; de Leon J
    Br J Psychiatry Suppl; 1989 Oct; (6):32-7. PubMed ID: 2695125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidepressants and the elderly.
    Peabody CA; Whiteford HA; Hollister LE
    J Am Geriatr Soc; 1986 Dec; 34(12):869-74. PubMed ID: 3537094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative effectiveness of tricyclic antidepressant versus monoamine oxidase inhibitor monotherapy for treatment-resistant depression.
    Kim T; Xu C; Amsterdam JD
    J Affect Disord; 2019 May; 250():199-203. PubMed ID: 30861462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The safety of switching rapidly from tricyclic antidepressants to monoamine oxidase inhibitors.
    Kahn D; Silver JM; Opler LA
    J Clin Psychopharmacol; 1989 Jun; 9(3):198-202. PubMed ID: 2738181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in antidepressant drugs.
    Priest RG; Baldwin DS; Bullock T; Kibel D; Smeyatsky N; Steinert J
    S Afr Med J; 1992 Jun; Suppl():1-4. PubMed ID: 1609337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.